Sjögren's syndrome-associated myositis with germinal centre-like structures

Autoimmunity Reviews

Volumn 16, Issue 2, 2017, Pages 154-158

  Espitia Thibault, Alexandra ^a   Masseau, Agathe ^a   Néel, Antoine ^a   Espitia, Olivier ^a   Toquet, Claire ^a   Mussini, Jean Marie ^a   Hamidou, Mohamed ^a  

^a HÔTEL DIEU   (France)

Author keywords

Germinal centre like structures; Muscular biopsy; Myositis; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CREATINE KINASE; HYDROXYCHLOROQUINE; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; AGED; CASE REPORT; CD4+ T LYMPHOCYTE; CHISHOLM AND MASON CLASSIFICATION; CLASSIFICATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; CRYOGLOBULINEMIA; DISEASE DURATION; DOPPLER ULTRASONOGRAPHY; ELECTROMYOGRAPHY; FAMILY HISTORY; FEMALE; FEVER; FOLLOW UP; GAIT DISORDER; GENERAL CONDITION DETERIORATION; GERMINAL CENTRE LIKE STRUCTURE; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; INCLUSION BODY MYOSITIS; LEG EDEMA; LOW DRUG DOSE; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MALE; MIDDLE AGED; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PROTEIN BLOOD LEVEL; REVIEW; SALIVARY GLAND BIOPSY; SIALOADENITIS; SJOEGREN SYNDROME; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION; XEROSTOMIA; COMPLICATION; GERMINAL CENTER; PATHOLOGY;

AGED; FEMALE; GERMINAL CENTER; HUMANS; MALE; MIDDLE AGED; MYOSITIS; SJOGREN'S SYNDROME;

EID: 85008196526     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.12.006     Document Type: Review

References (48)

1. [1] Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H.M., Alexander, E.L., Carsons, S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 (2002), 554–558.
2. [2] Costa, S., Quintin-Roué, I., Lesourd, A., Jousse-Joulin, S., Berthelot, J.-M., Hachulla, E., et al. Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort study. Rheumatology 54 (2015), 1056–1064.
3. [3] Risselada, A.P., Looije, M.F., Kruize, A.A., Bijlsma, J.W.J., van Roon, J.A.G., The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review. Semin Arthritis Rheum 42 (2013), 368–376.
4. [4] Delalande, S., de Seze, J., Fauchais, A.-L., Hachulla, E., Stojkovic, T., Ferriby, D., et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83 (2004), 280–291.
5. [5] Kruize, A.A., Hené, R.J., van der Heide, A., Bodeutsch, C., de Wilde, P.C., van Bijsterveld, O.P., et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 39 (1996), 297–303.
6. [6] Müller, K., Oxholm, P., Mier-Madsen, M., Wiik, A., Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations. Scand J Rheumatol 18 (1989), 29–31.
7. [7] Vidal, E., Delaire, L., Berdah, J.F., Ranger, S., Collineau, M., Jauberteau-Marchan, M.O., et al. Systemic signs of primary Gougerot-Sjögren syndrome. 48 cases. Ann Med Interne 145 (1994), 168–174.
8. [8] Lindvall, B., Bengtsson, A., Ernerudh, J., Eriksson, P., Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 29 (2002), 717–725.
9. [9] Fauchais, A.L., Martel, C., Gondran, G., Lambert, M., Launay, D., Jauberteau, M.O., et al. Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9 (2010), 595–599.
10. [10] Giroux, M., Dequatre, N., Zéphir, H., Lacour, A., Vermersch, P., Polymyositis revealing a Sjogren's syndrome. Rev Neurol (Paris) 166 (2010), 96–99.
11. [11] Váncsa, A., Gergely, L., Ponyi, A., Lakos, G., Németh, J., Szodoray, P., et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Jt Bone Spine Rev Rhum 77 (2010), 125–130.
12. [12] Cody, D., Davidson, J., Juvenile dermatomyositis and Sjögren's syndrome occurring concurrently in an adolescent male. Rheumatology 41 (2002), 698–700.
13. [13] Holmes, M.V., Ioannou, Y., Borysiewicz, C., Sen, D., Juvenile dermatomyositis with Sjögren's syndrome. Clin Rheumatol 27:Suppl. 1 (2008), S3–S5.
14. [14] Ng, K.P., Ramos, F., Sultan, S.M., Isenberg, D.A., Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. Clin Rheumatol 28 (2009), 947–953.
15. [15] Derk, C.T., Vivino, F.B., Kenyon, L., Mandel, S., Inclusion body myositis in connective tissue disorders: case report and review of the literature. Clin Rheumatol 22 (2003), 324–328.
16. [16] Kanellopoulos, P., Baltoyiannis, C., Tzioufas, A.G., Primary Sjögren's syndrome associated with inclusion body myositis. Rheumatology 41 (2002), 440–444.
17. [17] Khraishi, M.M., Jay, V., Keystone, E.C., Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome. J Rheumatol 19 (1992), 306–309.
18. [18] Rojana-udomsart, A., Needham, M., Luo, Y.B., Fabian, V., Walters, S., Zilko, P.J., et al. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 113 (2011), 559–563.
19. [19] Poux, J.M., Peyronnet, P., Le Meur, Y., Favereau, J.P., Charmes, J.P., Leroux-Robert, C., Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren's syndrome. Clin Nephrol 37 (1992), 189–191.
20. [20] Pun, K.K., Wong, C.K., Tsui, E.Y., Tam, S.C., Kung, A.W., Wang, C.C., Hypokalemic periodic paralysis due to the Sjögren syndrome in Chinese patients. Ann Intern Med 110 (1989), 405–406.
21. [21] Alexander, E.L., Josifek, L., Provost, T.T., Alexander, G.E., Myositis/vasculitis in primary Sjögren's syndrome. Arthritis Rheum, 25, 1982.
22. [22] Bloch, K.J., Buchanan, W.W., Wohl, M.J., Bunim, J.J., Sjoegren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 44 (1965), 187–231.
23. [23] Bunim, J.J., A broader spectrum of Sjogren's syndrome and its pathogenetic implications. Ann Rheum Dis 20 (1961), 1–10.
24. [24] Colafrancesco, S., Priori, R., Gattamelata, A., Picarelli, G., Minniti, A., Brancatisano, F., et al. Myositis in primary Sjögren's syndrome: data from a multicentre cohort. Clin Exp Rheumatol 33 (2015), 457–464.
25. [25] García-Carrasco, M., Ramos-Casals, M., Rosas, J., Pallarés, L., Calvo-Alen, J., Cervera, R., et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81 (2002), 270–280.
26. [26] Kraus, A., Cifuentes, M., Villa, A.R., Jakez, J., Reyes, E., Alarcón-Segovia, D., Myositis in primary Sjögren's syndrome. Report of 3 cases. J Rheumatol 21 (1994), 649–653.
27. [27] Lazarus, M.N., Isenberg, D.A., Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome. Ann Rheum Dis 64 (2005), 1062–1064.
28. [28] Lin, D.-F., Yan, S.-M., Zhao, Y., Zhang, W., Li, M.-T., Zeng, X.-F., et al. Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome. Chin Med J (Engl) 123 (2010), 3252–3257.
29. [29] Molina, R., Provost, T.T., Arnett, F.C., Bias, W.B., Hochberg, M.C., Wilson, R.W., et al. Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med 80 (1986), 23–31.
30. [30] Skopouli, F.N., Dafni, U., Ioannidis, J.P., Moutsopoulos, H.M., Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 29 (2000), 296–304.
31. [31] Ramos-Casals, M., Brito-Zerón, P., Solans, R., Camps, M.-T., Casanovas, A., Sopeña, B., et al. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 53 (2014), 321–331.
32. [32] Vrethem, M., Lindvall, B., Holmgren, H., Henriksson, K.G., Lindström, F., Ernerudh, J., Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand 82 (1990), 126–131.
33. [33] Alberici, F., Martorana, D., Vaglio, A., Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 30:Suppl. 1 (2015), i37–i45.
34. [34] Alexander, E.L., Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19 (1993), 869–908.
35. [35] Fox, R.I., Howell, F.V., Bone, R.C., Michelson, P., Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum 14 (1984), 77–105.
36. [36] Rumbach, L., Marescaux, C., Warter, J.M., Polymyositis associated with Gougerot-Sjögren syndrome. Rev Neurol (Paris) 139 (1983), 681–682.
37. [37] Serratrice, G., Pellissier, J.F., Roux, H., Gastaut, J.L., Acquaviva, P., Muscular lesions in Gougerot-Sjögren syndrome. Rev Rhum Mal Osteoartic 44 (1977), 479–488.
38. [38] Terrier, B., Lacroix, C., Guillevin, L., Hatron, P.-Y., Dhote, R., Maillot, F., et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum 57 (2007), 1520–1529.
39. [39] Kruize, A.A., Hené, R.J., Oey, P.L., Kater, L., Bijlsma, J.W., Neuro-musculo-skeletal manifestations in primary Sjögren's syndrome. Neth J Med 40 (1992), 135–139.
40. [40] Leroy, J.P., Drosos, A.A., Yiannopoulos, D.I., Youinou, P., Moutsopoulos, H.M., Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome. Arthritis Rheum 33 (1990), 1579–1581.
41. [41] Ponge, T., Mussini, J.M., Ponge, A., Forgeau, Y., Barrier, J., Cottin, S., et al. Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine. Rev Neurol (Paris) 143 (1987), 147–148.
42. [42] Hoogendijk, J.E., Amato, A.A., Lecky, B.R., Choy, E.H., Lundberg, I.E., Rose, M.R., et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14 (2004), 337–345.
43. [43] De Bleecker, J.L., Engel, A.G., Butcher, E.C., Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies. Neuromuscul Disord 6 (1996), 255–260.
44. [44] López De Padilla, C.M., Vallejo, A.N., Lacomis, D., McNallan, K., Reed, A.M., Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum 60 (2009), 1160–1172.
45. [45] Mashaly, R., Hauw, J.J., Poisson, M., Mussini, J.M., Escourolle, R., Buge, A., Polymyositis with infiltration by lymphoid follicles. Arch Neurol 38 (1981), 777–779.
46. [46] Wei, N., Pavlidis, N., Tsokos, G., Elin, R.J., Plotz, P.H., Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases. JAMA 246 (1981), 1921–1923.
47. [47] Chad, D., Good, P., Adelman, L., Bradley, W.G., Mills, J., Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 39 (1982), 186–188.
48. [48] Gutmann, L., Govindan, S., Riggs, J.E., Schochet, S.S. Jr., Inclusion body myositis and Sjogren's syndrome. Arch Neurol 42 (1985), 1021–1022.